Metraipolis › archive › dc_afd7ee042dd1
Fluvoxamine and lycopene alleviate cisplatin-induced kidney fibrosis by modulating miR-21 and fibrotic signaling pathways — Europe PMC PMID:42243346
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42243346
- DOI
- 10.1038/s41598-[numero omesso]-1
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T20:20:23.855Z
- SHA-256 of the archived text
9721ac825b7c8d8e34c2e6df70ee3c64a43c3e8cec01d650d38fccdc4d6d5d01- Stable URL of this page
https://metraipolis.com/documento/dc_afd7ee042dd1
How to cite
Fluvoxamine and lycopene alleviate cisplatin-induced kidney fibrosis by modulating miR-21 and fibrotic signaling pathways — Europe PMC PMID:42243346 — Europe PMC (en), https://europepmc.org/article/MED/42243346 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afd7ee042dd1 (Metraipolis archive dc_afd7ee042dd1, sha256 9721ac825b7c8d8e34c2e6df70ee3c64a43c3e8cec01d650d38fccdc4d6d5d01)
BibTeX
@misc{dcafd7ee042dd1,
title = {Fluvoxamine and lycopene alleviate cisplatin-induced kidney fibrosis by modulating miR-21 and fibrotic signaling pathways — Europe PMC PMID:42243346},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42243346},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afd7ee042dd1; sha256 9721ac825b7c8d8e34c2e6df70ee3c64a43c3e8cec01d650d38fccdc4d6d5d01},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42243346. Agents can read the archived copy with the MCP tool read_document.